Save your place

Sign in to WhoBought

Please try again later.

Janux Therapeutics, Inc. (JANX) institutional ownership

Market cap$1.4B SectorHealthcare
Funds holding · Q1 2026
186
reported JANX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
106 buyers · 80 sellers

Janux Therapeutics, Inc. (JANX) price and institutional activity

Dates

Q1 2026

$0 bought by 106 investors
BlackRockProsight Management, LP +104 more
$0 sold by 80 investors
State StreetJanus Henderson Group PLC +78 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Janux Therapeutics, Inc. (JANX) institutional activity · 186

Investor Type Est. change Change Δ Own Date
State Street · Reduced
Change −1.4M Date Q1 2026
State Street Reduced· Q1 2026 −1.4M Q1 2026
BlackRock · Added
Change +1.4M Date Q1 2026
BlackRock Added· Q1 2026 +1.4M Q1 2026
Prosight Management, LP · Added
Change +1.2M Date Q1 2026
Prosight Management, LP Added· Q1 2026 +1.2M Q1 2026
Janus Henderson Group PLC · Reduced
Change −1.2M Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −1.2M Q1 2026
Deep Track Capital, LP · Added
Change +1.1M Date Q1 2026
Deep Track Capital, LP Added· Q1 2026 +1.1M Q1 2026
FMR LLC · Reduced
Change −977K Δ Own −27.8% Date Q1 2026
FMR LLC Reduced· Q1 2026 −977K −27.8% Q1 2026
Orbimed Advisors LLC · Reduced
Change −971K Date Q1 2026
Orbimed Advisors LLC Reduced· Q1 2026 −971K Q1 2026
Nantahala Capital Management, LLC · New
Change +810K Date Q1 2026
Nantahala Capital Management, LLC New· Q1 2026 +810K Q1 2026
Readystate Asset Management LP · Reduced
Change −776K Date Q1 2026
Readystate Asset Management LP Reduced· Q1 2026 −776K Q1 2026
Irenic Capital Management LP · New
Change +766K Date Q1 2026
Irenic Capital Management LP New· Q1 2026 +766K Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −752K −68.1% Q1 2026
T. Rowe Price Associates · Reduced
Change −686K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −686K Q1 2026
Cormorant Asset Management, LP · Exited
Change −650K Δ Own −100.0% Date Q1 2026
Cormorant Asset Management, LP Exited· Q1 2026 −650K −100.0% Q1 2026
Vanguard · Added
Change +562K Date Q1 2026
Vanguard Added· Q1 2026 +562K Q1 2026
Tang Capital Management LLC · New
Change +500K Date Q1 2026
Tang Capital Management LLC New· Q1 2026 +500K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 186

Famous investor activity in Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. (JANX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Campbell David Alan · Director 2 operations 0
Price $4.21 Owned 698K Trade date Jul 8, 2026 Filed date Jul 10, 2026
Campbell David Alan Director 2 operations $4.21 0 698K Jul 8, 2026 Jul 10, 2026
Ra Capital Management, L.P. · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Ra Capital Management, L.P. Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Simson Jake · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Simson Jake Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Kung Winston · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Kung Winston Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Hernday Natasha · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Hernday Natasha Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Dobmeier Eric · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Dobmeier Eric Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Capps Vickie L. · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Capps Vickie L. Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Barrett Ronald W. · Director 2 operations 21K
Owned 16K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Barrett Ronald W. Director 2 operations 21K 16K Jun 11, 2026 Jun 12, 2026
Doyle Janeen Noel · Officer Sell −$57K
Price $14.03 Qty −4K Owned 76K Trade date Jun 2, 2026 Filed date Jun 4, 2026
Doyle Janeen Noel Officer Sell $14.03 −4K −$57K 76K Jun 2, 2026 Jun 4, 2026
Dobek Maria · Officer Sell −$29K
Price $14.17 Qty −2K Owned 32K Trade date May 11, 2026 Filed date May 13, 2026
Dobek Maria Officer Sell $14.17 −2K −$29K 32K May 11, 2026 May 13, 2026
Go William · Officer 2 operations 198K
Owned 154K Trade date Feb 2, 2026 Filed date Feb 4, 2026
Go William Officer 2 operations 198K 154K Feb 2, 2026 Feb 4, 2026
Meyer Andrew Hollman · Officer Sell −$26K
Price $13.73 Qty −2K Owned 83K Trade date Jan 2, 2026 Filed date Jan 2, 2026
Meyer Andrew Hollman Officer Sell $13.73 −2K −$26K 83K Jan 2, 2026 Jan 2, 2026
Diraimondo Thomas · Officer Sell −$34K
Price $13.73 Qty −3K Owned 124K Trade date Jan 2, 2026 Filed date Jan 2, 2026
Diraimondo Thomas Officer Sell $13.73 −3K −$34K 124K Jan 2, 2026 Jan 2, 2026
Diraimondo Thomas · Officer 2 operations 141K
Owned 110K Trade date Jan 2, 2026 Filed date Jan 2, 2026
Diraimondo Thomas Officer 2 operations 141K 110K Jan 2, 2026 Jan 2, 2026
Campbell David Alan · Director Sell −$111K
Price $13.73 Qty −8K Owned 285K Trade date Jan 2, 2026 Filed date Jan 2, 2026
Campbell David Alan Director Sell $13.73 −8K −$111K 285K Jan 2, 2026 Jan 2, 2026
15 of 29
15 of 29 Sign in to continue to older insider transactions.

Janux Therapeutics, Inc. (JANX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ra Capital Management, L.P. 10.4M
% of shares outstanding 20.0% Filing date Oct 22, 2024
Ra Capital Management, L.P. 10.4M 20.0% Oct 22, 2024
Janus Henderson Group PLC 4.2M
% of shares outstanding 6.9% Filing date May 15, 2026
Janus Henderson Group PLC 4.2M 6.9% May 15, 2026
Bregua Corp 3.0M
% of shares outstanding 5.8% Filing date Nov 4, 2024
Bregua Corp 3.0M 5.8% Nov 4, 2024
Point72 Asset Management, L.P. 3.1M
% of shares outstanding 5.0% Filing date Apr 29, 2026
Point72 Asset Management, L.P. 3.1M 5.0% Apr 29, 2026
Paradigm Biocapital Advisors LP 2.6M
% of shares outstanding 5.0% Filing date Oct 23, 2024
Paradigm Biocapital Advisors LP 2.6M 5.0% Oct 23, 2024
Campbell David Alan 2.6M
% of shares outstanding 4.8% Filing date Nov 14, 2024
Campbell David Alan 2.6M 4.8% Nov 14, 2024
FMR LLC 2.5M
% of shares outstanding 4.2% Filing date May 6, 2026
FMR LLC 2.5M 4.2% May 6, 2026
State Street Corporation 2.5M
% of shares outstanding 4.1% Filing date May 12, 2026
State Street Corporation 2.5M 4.1% May 12, 2026
8 of 12

Janux Therapeutics, Inc. (JANX) ownership FAQ

Who owns JANX?

186 reporting institutions disclosed JANX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.